FDCDDQ
ANIP icon

Federation des caisses Desjardins du Quebec’s ANI Pharmaceuticals ANIP Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
31,533
+4,603
+17% +$369K 0.01% 718
2026
Q1 		$2.07M Sell
26,930
-12,461
-32% -$973K 0.01% 740
2025
Q4 		$3.11M Buy
39,391
+221
+0.6% +$19.1K 0.01% 578
2025
Q3 		$3.59M Buy
39,170
+7,695
+24% +$627K 0.01% 513
2025
Q2 		$2.06M Buy
31,475
+7,200
+30% +$469K 0.01% 653
2025
Q1 		$1.63M Buy
24,275
+3,225
+15% +$193K 0.01% 680
2024
Q4 		$1.16M Buy
21,050
+1,500
+8% +$86.1K 0.01% 762
2024
Q3 		$1.17M Hold
19,550
– – 0.01% 749
2024
Q2 		$1.24M Sell
19,550
-1,600
-8% -$104K 0.01% 699
2024
Q1 		$1.17M Hold
21,150
– – 0.01% 675
2023
Q4 		$1.17M Hold
21,150
– – 0.01% 580
2023
Q3 		$1.23M Buy
21,150
+3,200
+18% +$185K 0.01% 526
2023
Q2 		$966K Hold
17,950
– – 0.01% 615
2023
Q1 		$713K Buy
+17,950
New +$757K 0.01% 677
2022
Q4 		– Sell
-17,800
Closed -$572K – 2483
2022
Q3 		$572K Buy
17,800
+1,800
+11% +$61.6K 0.01% 734
2022
Q2 		$475K Hold
16,000
– – 0.01% 804
2022
Q1 		$450K Hold
16,000
– – ﹤0.01% 874
2021
Q4 		$737K Buy
16,000
+10,849
+211% +$466K 0.01% 746
2021
Q3 		$169K Buy
+5,151
New +$160K ﹤0.01% 1216
2020
Q4 		– Sell
-38,850
Closed -$1.1M – 2326
2020
Q3 		$1.1M Hold
38,850
– – 0.02% 540
2020
Q2 		$1.26M Buy
38,850
+4,150
+12% +$149K 0.02% 491
2020
Q1 		$1.43M Buy
34,700
+15,700
+83% +$835K 0.02% 432
2019
Q4 		$1.17M Buy
19,000
+3,000
+19% +$199K 0.02% 615
2019
Q3 		$1.17M Hold
16,000
– – 0.02% 602
2019
Q2 		$1.31M Buy
16,000
+9,017
+129% +$641K 0.02% 556
2019
Q1 		$492K Buy
+6,983
New +$411K 0.01% 744

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ANIP Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its ANI Pharmaceuticals (ANIP) stake by 17% in Q2 2026, buying an estimated $369K and bringing the position to 31,533 shares worth $2.61M. The position accounts for 0.01% of the portfolio, ranked #718.

Federation des caisses Desjardins du Quebec first reported a position in ANIP in Q1 2019 and has held it in 26 quarters since. The position peaked at $3.59M in Q3 2025. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 31,533 shares of ANI Pharmaceuticals worth $2.61M as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 4,603 ANI Pharmaceuticals shares in Q2 2026, an estimated $369K.
  • ANI Pharmaceuticals made up 0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #718 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in ANI Pharmaceuticals in Q1 2019 and has held it in 26 quarters since.
  • Federation des caisses Desjardins du Quebec's ANI Pharmaceuticals position peaked at $3.59M in Q3 2025.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.